An Observational Study on the Identification of Prescription Patterns of STAFEN Cap

N/AUnknownNCT06204380

Hanlim Pharm. Co., Ltd.4,000 enrolled

Overview

An observational study on the identification of prescription patterns of STAFEN Cap., changes in blood lipid concentration, and statin-related muscle symptoms in Korean patients with mixed dyslipidemia

This study aims to observe the effectiveness of STAFEN capsule such as changes in blood lipid concentration and safety including statin-related muscle symptoms, and prescription patterns under daily clinical treatment in patients who have been prescribed STAFEN capsules for the treatment of complex dyslipidemia.

Study Type

OBSERVATIONAL

Enrollment

4,000

Conditions

Mixed Dyslipidemia

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adults over 19 years of age 2. A patient diagnosed with mixed dyslipidemia 3. A patient who was first prescribed a STAFEN cap. for the purpose of treating mixed dyslipidemia according to the clinician's judgment 4. A patient who voluntarily agreed in writing to this study Exclusion Criteria: 1. Pregnant women, lactating women, or those planning to conceive 2. A person who is prohibited from administering the STAFEN cap. under the permit 3. If the person in charge of other clinical studies and the person in charge deems it inappropriate to be the subject of this clinical study

Locations (1)

Delphoe Clinic

Gangneung-si, South Korea

RECRUITING

Outcomes

Primary Outcomes

Target triglyceride rate at 6 months of STAFEN capsule prescription compared to baseline

Time frame: at 6 months of STAFEN capsule prescription compared to baseline

Central Contacts

Heebaek Park

CONTACT

01055279616 thyroid62@hanmail.net

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.